Covid-19 Vaccine Stocks

Schwab Network

English - May 12, 2021 19:07 - 6 minutes - 31.5 MB - ★★★★★ - 23 ratings
News Commentary News Business News business news news commentary news Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Takeaways From Today's CPI Report

Next Episode: Dynatrace CEO On The Growth Of Cloud Companies In A Post-Covid World

CFRA has a buy rating on the Pfizer (PFE) stock with a $45 price target. They also have a buy rating on Johnson & Johnson (JNJ) with a $177 price target, as well as Novavax (NVAX) with a $200 price target. Sel Hardy examines the outlook for these pharmaceutical stocks.